Advertisement

Allgemeine Maßnahmen

Conference paper
  • 10 Downloads
Part of the Interdisziplinäre Gastroenterologie book series (GASTROENTEROLOG)

Zusammenfassung

Allgemeine Maßnahmen beim Gastroduodenalulcus sind für den Arzt und besonders auch für den Patienten ein so fester Bestandteil der Ulcustherapie, daß sie kaum noch in Frage gestellt werden. Bestimmte Diäten gelten als günstig, ändere als schädlich. Eine schädliche Wirkung wird ferner manchen Drogen, Genußmitteln und psychischen Faktoren wie dem Streß und seelischen Belastungen zugeschrieben. Viele dieser Anschauungen beruhen auf alten Überlieferungen, Einzelbeobachtungen und auch auf unbewiesenen Zusammenhängen. Sollte einmal ein solches allgemein akzeptiertes Urteil durch kontrollierte Studien widerlegt werden, ist es sehr schwierig, diese Vorurteile zu revidieren.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aeginata, Paulus: The seven books; Übersetzt von F.Adams, Vol. 1, Book III, Chap. 37. London: Sydenham Soc. 1844Google Scholar
  2. 2.
    Avicenna : A treatise on the Canon of Medicine of Avicenna. Übersetzt von O.C.Gruner. London: Luzac 1930Google Scholar
  3. 3.
    Bachrach, W.H.: Reserpine, gastric secretion, and peptic ulcer. Amer. J. dig. Dis. 4, 117–124(1959)PubMedCrossRefGoogle Scholar
  4. 4.
    Bergmann, G., v.: Ulcus duodeni und vegetatives Nervensystem. Beri. klin. Wschr. 50, 2374(1913)Google Scholar
  5. 5.
    Bingle, J.R, Lennard-Jones, J.E.: Some factors in the assessment of gastric antisecretory drugs by a sampling technique. Gut i, 337–344 (1960)CrossRefGoogle Scholar
  6. 6.
    Birnbaum, D.: Peptic ulcer and the central nervous system - aetiology and management. Clinics Gastroent. 2,245–257 (1973)Google Scholar
  7. 7.
    Birnbaum, D., Karmeli, F., Makonen, Tefera: The effect of diazepam on human gastric secretion. Gut 12, 616–618 (1971)PubMedCrossRefGoogle Scholar
  8. 8.
    Black, D.A.K., Rose, G.O., Brewer, D.D.: Controlled trial of prednisone in adult patients with the nephrotic syndrome. Brit. med. J. 3, 421–426 (1970)PubMedCrossRefGoogle Scholar
  9. 9.
    Bockus, H.L.: Management of uncomplicated peptic ulcer. In: Gastroenterology, part I. Bockus, H.L. (ed.), pp.674–709. Philadelphia: Saunders 1974Google Scholar
  10. 10.
    Boerger, H. W., Schafmayer, A., Arnold, R., Becker, H. D., Creutzfeldt, W.: Der Einfluß von Kaffee und Coffein of den Serumgastrinspiegel und die Säuresekretion beim Menschen. Dtsch. med. Wschr. 101, 455–457 (1976)Google Scholar
  11. 11.
    Bonfils, S., Hardouin, J.P., Richir, C., Delbarré, F.: Considerations cliniques et experimentales sur la genèse des lesions gastriques (ulceres, hémorrhagies) provoqués par la phenylbutazone. Bull. Soc. Med. Hop. Paris 71, 114–123 (1955)PubMedGoogle Scholar
  12. 12.
    Brown, R. G., McKeown, T., Whitfield, A. G. W.: A note on the association between smoking and disease in man in the seventh decade. Brit. J. Prev. Soc. Med. 11, 162–164 (1976)Google Scholar
  13. 13.
    Buchman, E., Kaung, D.T., Dolan, K., Knapp, R.N.: Unrestricted diet in the treatment of duodenal ulcer. Gastroenterology 56, 1016–1020 (1969)PubMedGoogle Scholar
  14. 14.
    Chvasta, T.E., Cooke, R.R.: The effect of several ulcerogenic drugs on the canine gastric mucosal barrier. J. Lab. din. Invest. 79, 302–315 (1972)Google Scholar
  15. 15.
    Celsus: Of Medicine: Übersetzt von J.Greive, Book IV, Chap. V. London: Wilson and Durham 1956Google Scholar
  16. 16.
    Conn, H.O., Blitzer, B. L.: Non association of adrenocorticosteroid therapy and peptic ulcer. New. Engl. J. Med. 294, 473–479 (1977)CrossRefGoogle Scholar
  17. 17.
    Cushing, H.: Peptic ulcers and the interbrain. Surg. Gynec. Obstet. 55, 1–34 (1932)Google Scholar
  18. 18.
    Doll, R., Avery-Jones, F., Pygott, F.: Effect of smoking on the production and maintenance of gastric and duodenal ulcers. Lancet 1958 1, 657–662PubMedCrossRefGoogle Scholar
  19. 19.
    Doll, R., Friedlander, P., Pygott, F.: Dietetic treatment of peptic ulcer. Lancet 1956 1, 5- 9CrossRefGoogle Scholar
  20. 20.
    Doll, R., Pygott, F.: Factors influencing the rate of healing of gastric ulcers. Admission to hospital, phenobarbitone, and ascorbic acid. Lancet1952 1, 171–175Google Scholar
  21. 21.
    Douglas, R. A., Johnston, E. D.: Aspirin and chronic gastric ulcer. Med. J. Aust. 2, 893- 897(1961)Google Scholar
  22. 22.
    Drenick, E. J.: Reserpine in peptic ulcer. Amer. J. dig. Dis. 1, 521–525 (1956)PubMedCrossRefGoogle Scholar
  23. 23.
    Duggan, J.M.: Aspirin ingestion and perforated peptic ulcer. Gut 13, 631–633 (1972)PubMedCrossRefGoogle Scholar
  24. 24.
    Friedman, G.D., Siegelaub, A.B., Seltzer, C.C.: Cigarettes, alcohol, coffee, and peptic ulcer. New. Engl. J. Med. 290, 469–473 (1974)PubMedCrossRefGoogle Scholar
  25. 25.
    Fordtran, J.S., Walsh, J.H.: Gastric acid secretion rate and buffer content in the stomach after eating. J. din. Invest. 52, 645–657 (1973)Google Scholar
  26. 26.
    Garb, A. E., Soule, E.H., Bartholomew, L. G., Cain, J.C.: Steroid-induced gastric ulcer. Arch, intern. Med. 116, 899–906 (1965)CrossRefGoogle Scholar
  27. 27.
    Geall, M.G., Phillips, S. F., Summerskill, W. H. J.: Profile of gastric potential difference in man; effects of aspirine, alcohol, bile, and endogenous acid. Gastroenterology 58, 437–443 (1970)PubMedGoogle Scholar
  28. 28.
    Gillies, M., Skyring, A.: Gastric ulcer, duodenal ulcer, and gastric carcinoma: a case controll study of certain social and environmental factors. Med. J. Aust. 2, 1132–1136 (1968)PubMedGoogle Scholar
  29. 29.
    Gurd, F.N., McClelland, R.N.: Trauma workshop report: the gastric intestinal tract in trauma. J. Trauma 11, 1089 (1970)CrossRefGoogle Scholar
  30. 30.
    Hunter, W.: The successful cure of a severe disorder of the stomach by milk taken in small quantities at once. Med. Obs. Soc. Phys. London 6,310–318 (1784)Google Scholar
  31. 31.
    Hurst, A.F., Steward, M.J.: Gastric and duodenal ulcer. London: Oxford Univ. Press 1929Google Scholar
  32. 32.
    Ippoliti, A. F., Maxwell, V., Isenberg, J. I.: The effect of various forms of milk on gastricacid secretion. Ann. intern. Med. 84, 286–289 (1976)PubMedGoogle Scholar
  33. 33.
    Kalk, H.: In: Handbuch innere Med. Katsch, G., Pickert, H. (Hrsg.), Bd. III, S. 680f. Berlin, Göttingen, Heidelberg: Springer 1953Google Scholar
  34. 34.
    Kirsner, J.B., Palmer, W.L.: The effect of various antacids on the hydrogen - ion concentration of the gastric contents. Amer. J. dig. Dis. 7,85 (1940)CrossRefGoogle Scholar
  35. 35.
    Koch, H., Demling, L.: “Condiments” acta hepato-gastroent. 21, 377–379 (1974)Google Scholar
  36. 36.
    Konturek, S.J., Salomon, T.E., McGreight, W.G., Johnson, L. R., Jacobson, E. D.: Effects of nicotine on gastrointestinal secretions. Gastroenterology 60, 1098–1105 (1971)PubMedGoogle Scholar
  37. 37.
    Kopenhagen Study Group for liver disease: Effect of prednisone on the survival of patients with cirrhosis of the liver. Lancet 1969 1, 119–121Google Scholar
  38. 38.
    Langman, M.J.S.: The medical treatment of gastric and duodenal ulcer. Postgrad, med. J. 44, 603–607 (1968)CrossRefGoogle Scholar
  39. 39.
    Lawrence, J.S.: Dietetic and other methods in the treatment of peptic ulcer. Lancet 1952 1, 482–485PubMedCrossRefGoogle Scholar
  40. 40.
    Lenhartz, H. A.D.: Eine neue Behandlung des Ulcus ventriculi. Dtsch. med. Wschr. 30, 412–413 (1904)Google Scholar
  41. 41.
    Lennard-Jones, J. E., Barbouris, N.: Effect of different foods on the acidity of the gastric contents in patients with duodenal ulcer. Part I: A comparison between two “therapeutic” diets an freely-chosen meals. Gut 6,113–117 (1965)PubMedCrossRefGoogle Scholar
  42. 42.
    Mahl, G.F.: Anxiety, HCL secretion, and peptic ulcer etiology. Psychosom. Med. 12, 159–169(1950)Google Scholar
  43. 43.
    Malchow, H., Sewing, K.-F., Albinus, M., Born, H., Schomerus, H., Dölle, W.: Cimetidine in der Behandlung des peptischen Ulcus. Dtsch. med. Wschr. 103, 149–152 (1978)PubMedCrossRefGoogle Scholar
  44. 44.
    Mauer, E.F.: The toxic effects of phenylbutazone (Butazolidin). New. Engl. J. Med. 253,404–410(1955)Google Scholar
  45. 45.
    Max, M., Menguy, R.: Influence of aspirin and phenylbutazone on rate of turnover of gastric mucosal cells. Digestion 2,67–72 (1969)CrossRefGoogle Scholar
  46. 46.
    Manson, R.R.: Cigarette smoking and body form in peptic ulcer. Gastroenterology 58, 337–344(1970)Google Scholar
  47. 47.
    Moore, J.G., Englert, E.: Circadian rhythm of gastric acid secretion in man. Nature 226, 1261–1262(1970)PubMedCrossRefGoogle Scholar
  48. 48.
    Nikol, B.M.: Control of gastric acidity in peptic ulcer. Lancet1939 II, 881–884CrossRefGoogle Scholar
  49. 49.
    Packard, R.S.: Smoking and the alimentary tract: a review. Gut 1, 171–174 (1960)PubMedCrossRefGoogle Scholar
  50. 50.
    Peterson, W.L., Sturdevant, A.L.R., Frankl, H.D., Richardson, C.T., Isenberg, J.L, Elashoff, J.D., Sones, J.Q., Gross, R.A., McCallum, R.W., Fordtran, J.S.: Healing of duodenal ulcer with an antacid regimen. New Engl. J. Med. 291, 341–345 (1977)CrossRefGoogle Scholar
  51. 51.
    Rhodes, J., Barnado, D.E., Phillips, S.F., Rovelstad, R.K., Hofman, A.F.: Increased reflux of bile into stomach in patients with gastric ulcer. Gastroenterology 56, 241–252 (1969)Google Scholar
  52. 52.
    Robbins, R., Idjadi, F., Stahl, W.M., Essiet, G.: Studies of gastric secretion in stressed patients. Ann. Surg.115, 555–562 (1972)CrossRefGoogle Scholar
  53. 53.
    Rösch, W.: DiskussionsbemerkungGoogle Scholar
  54. 54.
    Rokitansky, K.: Handbuch der speziellen pathologischen Anatomie, II. Band. Wien: Braunmüller und Seidel 1842Google Scholar
  55. 55.
    Rothermich, N.O.: An extended study of indomethacin in clinical pharmacology. J. Amer. med. Ass. 195, 531–536 (1966)CrossRefGoogle Scholar
  56. 56.
    Sanchez-Palomera, E.: The action of spices on the acid gastric secretion, on the apetite and on the caloric intake. Gastroenterology 18, 254–286 (1951)PubMedGoogle Scholar
  57. 57.
    Schneider, M. A., Luca, V., de, Gray, S.J.: The effect of spice ingestion upon the stomach. Amer. J. Gastroent. 26,722–732 (1956)PubMedGoogle Scholar
  58. 58.
    Sippy, B.W.: Gastric and duodenal ulcer: medical cure by an efficient removal of gastric juice corrosion. J. Amer. med. Ass. 64, 1625–1630 (1915)CrossRefGoogle Scholar
  59. 59.
    Solomon, T.E., Jacobson, E. D.: Cigarette smoking and duodenal ulcer disease. New. Engl. J. Med. 286, 1212–1213 (1972)PubMedCrossRefGoogle Scholar
  60. 60.
    Sperling, I. L.: Adverse reactions with long-term use of phenylbutazone and oxyphen- butazone. Lancet 1969 II, 535–537CrossRefGoogle Scholar
  61. 61.
    Stacher, G., Berner, P., Naske, R., Schuster, P., Bauer, P., Starkes, H., Schulze, D.: Effect of hypnotic suggestion of relaxation on basal and betazole stimulated gastric acid secretion. Gastroenterology 68 ,656–659 (1975)PubMedGoogle Scholar
  62. 62.
    Truelove, S.C.: Stilboestrol phenobarbitone and diet in chronical duodenal ulcer. Brit, med. J. 1960 II, 559–566CrossRefGoogle Scholar
  63. 63.
    Welsh, J.D.: Diet therapie of peptic ulcer disease. Gastroenterology 72, 740–745 (1977)PubMedGoogle Scholar
  64. 64.
    Wetterhus, S., Aubert, E., Berg, C. E., Bjerkset, T., Halvoorsen, L., Hovdenak, N., Myren, J., Roland, M., Sigstad, H., Guldahl, M.: The effect of trimipramine (Surmontil) on symptoms and healing of peptic ulcer. A double blind study. Scand. J. Gastroent. 12, Suppl. 43, 33–38(1976)Google Scholar
  65. 65.
    Wilkinson, A. R., Johnston, D.: Inhibitory effect of cigarette smoking on gastric secretion stimulated by pentagastrin in man. Lancet 1971 II, 628–638CrossRefGoogle Scholar
  66. 66.
    Wolf, S., Wolff, H. G.: Human gastric function. New York: Oxford Univ. Press 1943Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1978

Authors and Affiliations

  • K. Ewe

There are no affiliations available

Personalised recommendations